INS and Hypoglycemia: Due to hypoglycaemia (2.0∼3.0 mmol/L) and frequent drowsiness, insulin was changed to glibenclamide (0.06 mg/kg/d) at the age of three months, which was discontinued after the genetic diagnosis at the age of 20 months.